Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

I read with interest the subgroup analysis of the ARTESiA trial recently published in Lancet Neurology....

Authors

Vittorio Pengo (ORCID: https://orcid.org/0000-0003-2064-6071)

Publication Details

Journal: Bleeding Thrombosis and Vascular Biology
Published: 2025-04-16
DOI: https://doi.org/10.4081/btvb.2025.179
Primary Topic: Atrial Fibrillation Management and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

Vittorio Pengo

Apr 16, 2025

1 links

Bleeding Thrombosis and Vascular Biology

Atrial Fibrillation Management and Outcomes

article

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

Vittorio Pengo

April 16, 2025article en

Abstract

I read with interest the subgroup analysis of the ARTESiA trial recently published in Lancet Neurology....

Bleeding Thrombosis and Vascular BiologyVol. 4(2)

Openalex Percentile: Top 87%

Atrial Fibrillation Management and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t — Vittorio Pengo · Bleeding Thrombosis and Vascular Biology (2025) | TGRS Research Map | TGRS

Comment on&lt;b&gt; "&lt;/b&gt;Apixaban &lt;i&gt;vs.&lt;/i&gt; aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

Authors

Publication Details

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Comment on<b> "</b>Apixaban <i>vs.</i> aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled t